Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancers (Nature, (2018), 554, 7691, (189-194), 10.1038/nature25475)

David M. Hyman; Sarina A. Piha-Paul; Helen Won; Jordi Rodon; Cristina Saura; Geoffrey I. Shapiro; Dejan Juric; David I. Quinn; Victor Moreno; Bernard Doger; Ingrid A. Mayer; Valentina Boni; Emiliano Calvo; Sherene Loi; Albert C. Lockhart; Joseph P. Erinjeri; Maurizio Scaltriti; Gary A. Ulaner; Juber Patel; Jiabin Tang; Hannah Beer; S. Duygu Selcuklu; Aphrothiti J. Hanrahan; Nancy Bouvier; Myra Melcer; Rajmohan Murali; Alison M. Schram; Lillian M. Smyth; Komal Jhaveri; Bob T. Li; Alexander Drilon; James J. Harding; Gopa Iyer; Barry S. Taylor; Michael F. Berger; Richard E. Cutler; Feng Xu; Anna Butturini; Lisa D. Eli; Grace Mann; Cynthia Farrell; Alshad S. Lalani; Richard P. Bryce; Carlos L. Arteaga; Funda Meric-Bernstam; José Baselga; David B. Solit

ArticleOPEN ACCESS

Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancers (Nature, (2018), 554, 7691, (189-194), 10.1038/nature25475)

Nature

DOI: 10.1038/s41586-019-0974-0

11Citations

9Readers

Abstract

The ‘Competing interests’ statement of this Article has been updated; please see the accompanying Amendment. The original Article has not been corrected online.

Cite

CITATION STYLE

APA

Hyman, D. M., Piha-Paul, S. A., Won, H., Rodon, J., Saura, C., Shapiro, G. I., … Solit, D. B. (2019, February 28). Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancers (Nature, (2018), 554, 7691, (189-194), 10.1038/nature25475). Nature. Nature Publishing Group. https://doi.org/10.1038/s41586-019-0974-0

Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancers (Nature, (2018), 554, 7691, (189-194), 10.1038/nature25475)

Abstract

Cite

Register to see more suggestions